Antiviral response in vernal keratoconjunctivitis may be protective against COVID-19.

Leonardi, Andrea; Rosani, Umberto; Cavarzeran, Fabiano; Daull, Philippe; Garrigue, Jean-Sebastien; Paola, Brun

Leonardi, Andrea; Rosani, Umberto; Cavarzeran, Fabiano; Daull, Philippe; Garrigue, Jean-Sebastien; Paola, Brun.

Afiliação

Leonardi A; Department of Neuroscience, Ophthalmology Unit, University of Padua, Padova, Italy.
Rosani U; Department of Biology, University of Padova, Padova, Italy.
Cavarzeran F; Department of Neuroscience, Ophthalmology Unit, University of Padua, Padova, Italy.
Daull P; Santen SAS, Evry, France.
Garrigue JS; Santen SAS, Evry, France.
Paola B; Department of Molecular Medicine, Histology Unit, University of Padova, Padova, Italy.

Allergy ; 77(1): 298-300, 2022 01.

Article em En | MEDLINE | ID: mdl-34390598

Assuntos

COVID-19; Conjuntivite Alérgica; Antivirais/uso terapêutico; Conjuntivite Alérgica/tratamento farmacológico; Humanos; Peptidil Dipeptidase A; SARS-CoV-2

Palavras-chave

ACE2; COVID-19; SARS-CoV-2; antiviral factors; vernal keratoconjuntivitis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Conjuntivite Alérgica / COVID-19 Limite: Humans Idioma: En Revista: Allergy Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google